What Is Adultification Bias?

Lauren Nicks recalls experiencing adultification bias at a summer camp, where she was scolded for her clothing and perceived as more mature than her age. This bias disproportionately affects Black girls, who are often treated harshly in education and juvenile justice systems. Signs of trauma from this bias can include changes in behavior or academic…

Read More

Novel Drug Shows a Signal to Improve nHCM

A phase 2 trial investigating a new drug, ninerafaxstat, showed promising results in improving cardiac function in patients with nonobstructive hypertrophic cardiomyopathy (nHCM). While overall cardiovascular outcomes did not show significant improvement, a post hoc analysis revealed that patients with severe symptoms experienced measurable improvements in heart failure symptoms and exercise capacity. This suggests potential…

Read More

Lupin Gets CDSCO Panel Nod to Study Glycopyrronium Bromide, Vilanterol Trifenatate powder for inhalation in capsule

Lupin has received approval from the CDSCO panel to study a powder for inhalation capsule containing Glycopyrronium Bromide and Vilanterol Trifenatate. This medication is intended for the treatment of respiratory conditions. The company will conduct further research on the product. Cookies are used on the website for analytics and advertising purposes. Continuing to use the…

Read More

A Guide for Specialty Practices Navigating a Future of Healthcare that Does Good and Feels Good

The traditional fee-for-service healthcare model has been foundational in providing access to healthcare services, but as the industry shifts towards outcomes-based care, specialty practices face unique challenges and opportunities. These practices, including dermatology, ophthalmology, and aesthetics, can lead in healthcare innovation by integrating medical wellness into their services. The focus on wellness aligns with consumer…

Read More

Readout Newsletter: Moderna, Vertex, Otsuka, Vera

Damian bids farewell in the final edition of The Readout at STAT after 8 years of covering biotech. Meghana Keshavan will continue the newsletter. European regulators find no link between new obesity medicines and suicidal thoughts. Moderna halts plans to invest in a Kenya manufacturing site for mRNA vaccines due to insufficient demand. Vertex Pharmaceuticals…

Read More

Subcutaneous infusion of levodopa-carbidopa beneficial for Parkinson’s disease

A study published in The Lancet Neurology showed that subcutaneous infusion of ND0612, a levodopa-carbidopa solution, increases on time without troublesome dyskinesia in Parkinson’s disease patients. The study, involving 381 participants, found that compared to oral levodopa-carbidopa, subcutaneous ND0612 provided an additional 1.72 hours of on time without troublesome dyskinesia. Other outcomes, such as daily…

Read More
error: Content is protected !!